萘普生与吡罗昔康。类风湿性关节炎的一项对比试验。
Naproxen and piroxicam. A comparative trial in rheumatoid arthritis.
作者信息
Huskisson E C, Greenwood A
出版信息
Eur J Rheumatol Inflamm. 1983;6(3):242-6.
PMID:6239778
Abstract
A single-blind crossover trial in 60 patients with rheumatoid arthritis showed that piroxicam, 20 mg daily and naproxen, 500 mg twice daily were comparable in both efficacy and tolerance.
摘要
一项针对60名类风湿性关节炎患者的单盲交叉试验表明，每日服用20毫克吡罗昔康和每日两次服用500毫克萘普生在疗效和耐受性方面相当。
Zotero 插件